Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPT-TAZ: Piperacillin/Tazobactam PK Modeling in Sepsis
NCT03748095Completed
- Sponsor
- Rouen University Hospital
- Start
- Mar 2019
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Open-label trial of piperacillin and tazobactam in sepsis (2 cohorts), sponsored by Rouen University Hospital. Primary endpoint: Area Under the Curve at 24 hours. Started Mar 2019; status: completed.
02
Drugs
piperacillintazobactam
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT03748095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03748095.